• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单倍体不足网络可识别低突变卵巢癌中可靶向的等位基因缺失模式。

Haploinsufficiency networks identify targetable patterns of allelic deficiency in low mutation ovarian cancer.

机构信息

Division of Gynecologic Oncology, Department of Reproductive Medicine, UCSD School of Medicine and UCSD Moores Cancer Center, 3855 Health Sciences Drive, La Jolla, California 39216, USA.

Centre de recherche en Cancérologie, INSERM 1052, CNRS 5286, Centre Léon Bérard, Université de Lyon, Lyon, France.

出版信息

Nat Commun. 2017 Feb 15;8:14423. doi: 10.1038/ncomms14423.

DOI:10.1038/ncomms14423
PMID:28198375
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5316854/
Abstract

Identification of specific oncogenic gene changes has enabled the modern generation of targeted cancer therapeutics. In high-grade serous ovarian cancer (OV), the bulk of genetic changes is not somatic point mutations, but rather somatic copy-number alterations (SCNAs). The impact of SCNAs on tumour biology remains poorly understood. Here we build haploinsufficiency network analyses to identify which SCNA patterns are most disruptive in OV. Of all KEGG pathways (N=187), autophagy is the most significantly disrupted by coincident gene deletions. Compared with 20 other cancer types, OV is most severely disrupted in autophagy and in compensatory proteostasis pathways. Network analysis prioritizes MAP1LC3B (LC3) and BECN1 as most impactful. Knockdown of LC3 and BECN1 expression confers sensitivity to cells undergoing autophagic stress independent of platinum resistance status. The results support the use of pathway network tools to evaluate how the copy-number landscape of a tumour may guide therapy.

摘要

特定致癌基因变化的鉴定使现代靶向癌症治疗成为可能。在高级别浆液性卵巢癌(OV)中,大部分遗传变化不是体细胞点突变,而是体细胞拷贝数改变(SCNAs)。SCNAs 对肿瘤生物学的影响仍知之甚少。在这里,我们构建了杂合不足网络分析,以确定在 OV 中哪种 SCNA 模式最具破坏性。在所有 KEGG 途径(N=187)中,自噬受到基因缺失的影响最大。与其他 20 种癌症类型相比,OV 在自噬和代偿性蛋白质稳态途径中受到的干扰最为严重。网络分析将 MAP1LC3B(LC3)和 BECN1 确定为最具影响力的基因。LC3 和 BECN1 表达的敲低使正在经历自噬应激的细胞对铂类耐药状态不敏感。结果支持使用途径网络工具来评估肿瘤的拷贝数景观如何指导治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df85/5316854/0d5481f78d27/ncomms14423-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df85/5316854/eaace2c28589/ncomms14423-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df85/5316854/4bd797bb148b/ncomms14423-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df85/5316854/27fc4e407f24/ncomms14423-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df85/5316854/3532eb30cd71/ncomms14423-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df85/5316854/0d5481f78d27/ncomms14423-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df85/5316854/eaace2c28589/ncomms14423-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df85/5316854/4bd797bb148b/ncomms14423-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df85/5316854/27fc4e407f24/ncomms14423-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df85/5316854/3532eb30cd71/ncomms14423-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df85/5316854/0d5481f78d27/ncomms14423-f5.jpg

相似文献

1
Haploinsufficiency networks identify targetable patterns of allelic deficiency in low mutation ovarian cancer.单倍体不足网络可识别低突变卵巢癌中可靶向的等位基因缺失模式。
Nat Commun. 2017 Feb 15;8:14423. doi: 10.1038/ncomms14423.
2
Autophagy gene haploinsufficiency drives chromosome instability, increases migration, and promotes early ovarian tumors.自噬基因单倍不足导致染色体不稳定,增加迁移,并促进早期卵巢肿瘤。
PLoS Genet. 2020 Jan 10;16(1):e1008558. doi: 10.1371/journal.pgen.1008558. eCollection 2020 Jan.
3
Robustness of the Autophagy Pathway to Somatic Copy Number Losses.自噬途径对体细胞拷贝数缺失的稳健性。
Cells. 2022 May 27;11(11):1762. doi: 10.3390/cells11111762.
4
Focal Recurrent Copy Number Alterations Characterize Disease Relapse in High Grade Serous Ovarian Cancer Patients with Good Clinical Prognosis: A Pilot Study.高级别浆液性卵巢癌患者具有良好临床预后时的疾病复发以局灶性反复出现的拷贝数改变为特征:一项初步研究。
Genes (Basel). 2019 Sep 5;10(9):678. doi: 10.3390/genes10090678.
5
Beclin-1 expression is retained in high-grade serous ovarian cancer yet is not essential for autophagy induction in vitro.Beclin-1表达在高级别浆液性卵巢癌中得以保留,但对体外自噬诱导并非必需。
J Ovarian Res. 2015 Aug 4;8:52. doi: 10.1186/s13048-015-0182-y.
6
Integrative prediction of gene function and platinum-free survival from genomic and epigenetic features in ovarian cancer.基于卵巢癌基因组和表观遗传特征的基因功能及无铂生存期的综合预测
Methods Mol Biol. 2013;1049:35-51. doi: 10.1007/978-1-62703-547-7_4.
7
Integrating a Next Generation Sequencing Panel into Clinical Practice in Ovarian Cancer.将下一代测序面板整合到卵巢癌的临床实践中。
Yonsei Med J. 2019 Oct;60(10):914-923. doi: 10.3349/ymj.2019.60.10.914.
8
Genomic classification of serous ovarian cancer with adjacent borderline differentiates RAS pathway and TP53-mutant tumors and identifies NRAS as an oncogenic driver.具有交界性分化的浆液性卵巢癌的基因组分类可区分 RAS 通路和 TP53 突变型肿瘤,并确定 NRAS 为致癌驱动基因。
Clin Cancer Res. 2014 Dec 15;20(24):6618-30. doi: 10.1158/1078-0432.CCR-14-1292. Epub 2014 Oct 14.
9
Nonequivalent gene expression and copy number alterations in high-grade serous ovarian cancers with BRCA1 and BRCA2 mutations.BRCA1 和 BRCA2 突变的高级别浆液性卵巢癌中基因表达和拷贝数改变的非等效性。
Clin Cancer Res. 2013 Jul 1;19(13):3474-84. doi: 10.1158/1078-0432.CCR-13-0066. Epub 2013 Apr 30.
10
BRCA1 deficiency induces protective autophagy to mitigate stress and provides a mechanism for BRCA1 haploinsufficiency in tumorigenesis.BRCA1 缺陷诱导保护性自噬以减轻应激,并为 BRCA1 杂合不足在肿瘤发生中的作用提供了一种机制。
Cancer Lett. 2014 Apr 28;346(1):139-47. doi: 10.1016/j.canlet.2013.12.026. Epub 2013 Dec 28.

引用本文的文献

1
Half the Chromosome It Used to Be: Identifying Cancer Treatments Targeting Aneuploid Losses.曾经染色体数量的一半:识别针对非整倍体缺失的癌症治疗方法。
Genes (Basel). 2025 Jun 14;16(6):708. doi: 10.3390/genes16060708.
2
Truncated DAPK Variants Restore Tumor Suppressor Activity and Synergize with Standard Therapies in High-Grade Serous Ovarian Cancer.截短的DAPK变体可恢复肿瘤抑制活性,并在高级别浆液性卵巢癌中与标准疗法协同作用。
Cancers (Basel). 2025 Jun 8;17(12):1910. doi: 10.3390/cancers17121910.
3
Screening Methods to Discover the FDA-Approved Cancer Drug Encorafenib as Optimally Selective for Metallothionein Gene Loss Ovarian Cancer.

本文引用的文献

1
Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer.人类高级别浆液性卵巢癌的综合蛋白质基因组特征分析
Cell. 2016 Jul 28;166(3):755-765. doi: 10.1016/j.cell.2016.05.069. Epub 2016 Jun 29.
2
Loss of Chromosome 8p Governs Tumor Progression and Drug Response by Altering Lipid Metabolism.8p 染色体缺失通过改变脂质代谢来控制肿瘤进展和药物反应。
Cancer Cell. 2016 May 9;29(5):751-766. doi: 10.1016/j.ccell.2016.04.003.
3
Coordinated Tumor Suppression by Chromosome 8p.8号染色体短臂的协同肿瘤抑制作用
发现FDA批准的癌症药物恩考芬尼对金属硫蛋白基因缺失的卵巢癌具有最佳选择性的筛选方法。
Genes (Basel). 2025 Jan 1;16(1):42. doi: 10.3390/genes16010042.
4
Autophagy unrelated transcriptional mechanisms of hydroxychloroquine resistance revealed by integrated multi-omics of evolved cancer cells.通过进化癌细胞的综合多组学揭示的羟氯喹耐药性的自噬无关转录机制
Cell Cycle. 2024 Apr;23(7-8):796-816. doi: 10.1080/15384101.2024.2402191. Epub 2024 Sep 19.
5
Chloroquine and Chemotherapeutic Compounds in Experimental Cancer Treatment.氯喹和化疗药物在癌症实验治疗中的应用。
Int J Mol Sci. 2024 Jan 12;25(2):945. doi: 10.3390/ijms25020945.
6
Discovery and development of botanical natural products and their analogues as therapeutics for ovarian cancer.植物天然产物及其类似物作为卵巢癌治疗药物的发现和开发。
Nat Prod Rep. 2023 Jul 19;40(7):1250-1270. doi: 10.1039/d2np00091a.
7
Lysophosphatidic acid suppresses apoptosis of high-grade serous ovarian cancer cells by inducing autophagy activity and promotes cell-cycle progression EGFR-PI3K/Aurora-A-geminin dual signaling pathways.溶血磷脂酸通过诱导自噬活性抑制高级别浆液性卵巢癌细胞凋亡,并通过表皮生长因子受体-磷脂酰肌醇-3-激酶/极光激酶A-双微体蛋白双重信号通路促进细胞周期进程。
Front Pharmacol. 2022 Dec 19;13:1046269. doi: 10.3389/fphar.2022.1046269. eCollection 2022.
8
Spontaneous Transformation of a p53 and Rb-Defective Human Fallopian Tube Epithelial Cell Line after Long Passage with Features of High-Grade Serous Carcinoma.经长期传代后,p53和Rb缺陷的人输卵管上皮细胞系发生自发转化,具有高级别浆液性癌的特征。
Int J Mol Sci. 2022 Nov 10;23(22):13843. doi: 10.3390/ijms232213843.
9
Combination of Autophagy Selective Therapeutics With Doxil: An Assessment of Pathological Toxicity.自噬选择性疗法与阿霉素联合应用:病理毒性评估
Front Toxicol. 2022 Jun 29;4:937150. doi: 10.3389/ftox.2022.937150. eCollection 2022.
10
Autophagy at the intersection of aging, senescence, and cancer.自噬在衰老、衰老和癌症中的交汇。
Mol Oncol. 2022 Sep;16(18):3259-3275. doi: 10.1002/1878-0261.13269. Epub 2022 Jul 9.
Cancer Cell. 2016 May 9;29(5):617-619. doi: 10.1016/j.ccell.2016.04.011.
4
Deletions linked to TP53 loss drive cancer through p53-independent mechanisms.与TP53缺失相关的缺失通过不依赖p53的机制驱动癌症。
Nature. 2016 Mar 24;531(7595):471-475. doi: 10.1038/nature17157. Epub 2016 Mar 16.
5
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).自噬监测检测方法的使用与解读指南(第3版)
Autophagy. 2016;12(1):1-222. doi: 10.1080/15548627.2015.1100356.
6
Protein Phosphorylation: A Major Switch Mechanism for Metabolic Regulation.蛋白质磷酸化:代谢调节的主要开关机制。
Trends Endocrinol Metab. 2015 Dec;26(12):676-687. doi: 10.1016/j.tem.2015.09.013. Epub 2015 Oct 20.
7
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer.重新思考卵巢癌II:降低高级别浆液性卵巢癌的死亡率
Nat Rev Cancer. 2015 Nov;15(11):668-79. doi: 10.1038/nrc4019.
8
A strategy to combine pathway-targeted low toxicity drugs in ovarian cancer.一种在卵巢癌中联合使用靶向通路的低毒性药物的策略。
Oncotarget. 2015 Oct 13;6(31):31104-18. doi: 10.18632/oncotarget.5093.
9
MouseMine: a new data warehouse for MGI.MouseMine:MGI的一个新数据仓库。
Mamm Genome. 2015 Aug;26(7-8):325-30. doi: 10.1007/s00335-015-9573-z. Epub 2015 Jun 20.
10
Characterization of twenty-five ovarian tumour cell lines that phenocopy primary tumours.对25种模拟原发性肿瘤的卵巢肿瘤细胞系的表征。
Nat Commun. 2015 Jun 17;6:7419. doi: 10.1038/ncomms8419.